Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.

Zhao LY, Zhang J, Guo B, Yang J, Han J, Zhao XG, Wang XF, Liu LY, Li ZF, Song TS, Huang C.

Cell Mol Biol (Noisy-le-grand). 2013 Nov 3;Suppl 59:OL1876-81.

PMID:
24199952
2.

CDK-associated Cullin 1 promotes cell proliferation with activation of ERK1/2 in human lung cancer A549 cells.

Chen TJ, Gao F, Yang T, Thakur A, Ren H, Li Y, Zhang S, Wang T, Chen MW.

Biochem Biophys Res Commun. 2013 Jul 19;437(1):108-13. doi: 10.1016/j.bbrc.2013.06.048. Epub 2013 Jun 24.

PMID:
23806693
3.

The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.

Chiu CY, Kuo KK, Kuo TL, Lee KT, Cheng KH.

Mol Cancer Res. 2012 Mar;10(3):415-27. doi: 10.1158/1541-7786.MCR-11-0293. Epub 2012 Jan 12.

4.

Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.

Zhang J, Lan SJ, Liu QR, Liu JM, Chen XQ.

Mol Pharmacol. 2013 May;83(5):1109-19. doi: 10.1124/mol.112.083634. Epub 2013 Mar 11.

5.

S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.

Wu R, Duan L, Ye L, Wang H, Yang X, Zhang Y, Chen X, Zhang Y, Weng Y, Luo J, Tang M, Shi Q, He T, Zhou L.

Int J Oncol. 2013 Mar;42(3):1001-10. doi: 10.3892/ijo.2013.1796. Epub 2013 Jan 23.

PMID:
23354417
6.

Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells.

Wu X, Zhao B, Cheng Y, Yang Y, Huang C, Meng X, Wu B, Zhang L, Lv X, Li J.

Toxicol Appl Pharmacol. 2015 Oct 1;288(1):74-83. doi: 10.1016/j.taap.2015.07.010. Epub 2015 Jul 17.

PMID:
26189965
7.
9.

KITENIN is associated with activation of AP-1 target genes via MAPK cascades signaling in human hepatocellular carcinoma progression.

Cho SB, Park YL, Park SJ, Park SY, Lee WS, Park CH, Choi SK, Heo YH, Koh YS, Cho CK, Chung IJ, Kim KK, Kim S, Joo YE.

Oncol Res. 2011;19(3-4):115-23.

PMID:
21473287
10.

Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells.

Yan F, Wang M, Li J, Cheng H, Su J, Wang X, Wu H, Xia L, Li X, Chang HC, Li Q.

Environ Toxicol Pharmacol. 2012 Mar;33(2):181-90. doi: 10.1016/j.etap.2011.12.006. Epub 2011 Dec 10.

PMID:
22222560
11.

Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.

Wiesenauer CA, Yip-Schneider MT, Wang Y, Schmidt CM.

J Am Coll Surg. 2004 Mar;198(3):410-21.

PMID:
14992744
12.

Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.

Li X, Lv Y, Yuan A, Yi S, Ma Y, Li Z.

Oncol Rep. 2010 Aug;24(2):441-8.

PMID:
20596631
13.
14.
15.

Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion.

Guo K, Liu Y, Zhou H, Dai Z, Zhang J, Sun R, Chen J, Sun Q, Lu W, Kang X, Chen P.

Cancer Sci. 2008 Mar;99(3):486-96. doi: 10.1111/j.1349-7006.2007.00702.x. Epub 2007 Dec 27.

16.

Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.

Gao Y, Lin LP, Zhu CH, Chen Y, Hou YT, Ding J.

Cancer Biol Ther. 2006 Aug;5(8):978-85. Epub 2006 Aug 3.

PMID:
16855382
17.

S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.

Wu R, Duan L, Cui F, Cao J, Xiang Y, Tang Y, Zhou L.

Exp Cell Res. 2015 Jun 10;334(2):228-38. doi: 10.1016/j.yexcr.2015.04.008. Epub 2015 Apr 20.

PMID:
25907296
18.

Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.

Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng Q, Lo CM, Poon RT, Fan ST.

Carcinogenesis. 2008 Nov;29(11):2096-105. doi: 10.1093/carcin/bgn203. Epub 2008 Sep 1.

PMID:
18765415
19.

Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.

Wang X, Bai H, Zhang X, Liu J, Cao P, Liao N, Zhang W, Wang Z, Hai C.

Carcinogenesis. 2013 Jun;34(6):1323-30. doi: 10.1093/carcin/bgt058. Epub 2013 Feb 12.

PMID:
23404993
20.

Supplemental Content

Support Center